All In Biotech

Drug Trial Radar · NCT00021528

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)

Sequenced Treatment Alternatives to Relieve Depression

Last checked: Nov 19, 2026Latest source record: Sep 25, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 4,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,000

Actual

Start

Jul 2001

Primary completion

Not stated

Study completion Sep 2006

Sponsor

Sponsor type
NIH
First posted
Jul 23, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

STAR\*D focuses on non-psychotic major depressive disorder in adults who are seen in outpatient settings. The primary purpose of this research study is to determine which treatments work best if the first treatment with medication does not produce an acceptable response. Participants will first receive citalopram, an SSRI medication; if symptoms remain after 8-12 weeks of treatment, up to four other levels of treatment will be offered, including cognitive therapy and other medications. There are no placebo treatments. Some patients may require a combination of two or more treatments to obtain full benefit. Participation could last from 15 to 27 months and involve up to 30 clinic visits. Participants will be interviewed by telephone throughout the study about their symptoms, daily functioning, treatment side effects, use of the health care system, and satisfaction with treatment. There will be a one-year follow up for participants once their depression has been successfully treated

Conditions

  • Depression

Interventions

  • citalopramDrug

  • BuproprionSRDrug

  • buspironeDrug

  • LithiumDrug

  • mirtazapineDrug

  • nortriptylineDrug

  • sertralineDrug

  • tranylcypromineDrug

  • VenlafaxineXRDrug

  • Cognitive TherapyBehavioral

  • T3 (Triiodothyronine)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

41 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham VA Medical Center

    Birmingham, Alabama

  • Tuscaloosa VA Mental Health Clinic - Veterans Only

    Tuscaloosa, Alabama

  • Tuscaloosa VA Primary Care Center

    Tuscaloosa, Alabama

  • Psychiatric Centers at San Diego

    Chula Vista, California

  • Harbor UCLA Family Health Care Center

    Harbor City, California

  • UCLA General Outpatient Psychiatry Clinic

    Los Angeles, California

  • UCLA Internal Medicine Clinic

    Los Angeles, California

  • UCSD Outpatient Psychiatric Services

    San Diego, California

  • Veterans Affairs Medical Center/FIRM Primary Care Clinic

    San Diego, California

  • Harbor UCLA Medical Center

    Torrance, California

  • Northwestern Outpatient Treatment Care Center

    Chicago, Illinois

  • University of Illinois at Chicago Clinic

    Chicago, Illinois

  • Evanston Outpatient Clinic

    Evanston, Illinois

  • COMCARE of Sedgwick County

    Wichita, Kansas

  • Psychiatric Outpatient Clinic

    Wichita, Kansas

  • Swampscott Family Doctors

    Boston, Massachusetts

  • Internal Medicine Associates

    Boston, Massachusetts

  • MGH/Charlestown Clinic

    Charlestown, Massachusetts

  • MGH/Salem Professional

    Salem, Massachusetts

  • General Psychiatric Ambulatory Clinic

    Ann Arbor, Michigan

  • Briarwood Family Practice Clinic

    Ann Arbor, Michigan

  • LIJ/Zucker Hillside Adult Ambulatory Care Center

    Glen Oaks, New York

  • LIJ North Shore Medical Group

    Lake Success, New York

  • UNC Chapel Hill General Medicine Clinic

    Chapel Hill, North Carolina

  • UNC Chapel Hill Adult Diagnostic & Treatment Clinic

    Chapel Hill, North Carolina

  • UNC Chapel Hill Family Practice Clinic

    Chapel Hill, North Carolina

  • Springer Family Medicine

    Tulsa, Oklahoma

  • Laureate Psychiatric Clinic & Hospital

    Tulsa, Oklahoma

  • Warren Clinic

    Tulsa, Oklahoma

  • Diversified Human Services Clinic

    Pittsburgh, Pennsylvania

  • Latterman Family Health Center

    Pittsburgh, Pennsylvania

  • Bellefield Clinic of WPIC

    Pittsburgh, Pennsylvania

  • AMPN Corkery, Heise & Dainesi

    Upper Saint Clair, Pennsylvania

  • Psychiatric Consultants, P.C.

    Nashville, Tennessee

  • Vanderbilt University Medical Center-Mental Health Center

    Nashville, Tennessee

  • Vine Hill Community Clinic

    Nashville, Tennessee

  • Centerstone/Luton Mental Health Services

    Nashville, Tennessee

  • The Holiner Psychiatric Group

    Dallas, Texas

  • UT Southwestern Family Medicine Clinic

    Dallas, Texas

  • MCV Primary Care Clinic

    Richmond, Virginia

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.